Alpheon
Country: Եվրոպական Միություն
language: շվեդերեն
source: EMA (European Medicines Agency)
PAR
(PAR)
22-10-2007
documentation_request_body
documentation_request_send
documentation_request_send
active_ingredient:
recombinant human interferon alfa-2a
MAH:
BioPartners GmbH
ATC_code:
L03AB04
INN:
interferon alfa-2a
therapeutic_group:
Immunstimulatorer,
therapeutic_area:
Hepatit C, kronisk
therapeutic_indication:
Adult patients with histologically proven chronic hepatitis C who are positive for hepatitis C virus (HCV) antibodies or HCV RNA and have elevated serum alanine aminotransferase (ALT) without liver decompensation. The efficacy of Interferon alfa-2a in the treatment of hepatitis C is enhanced when combined with ribavirin. Alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.
authorization_status:
Refused
